Targeted Capacity Expansion: Medication Assisted Treatment – Prescription Drug and Opioid Addiction Program
MAT-PDOA supports programs that expand/enhance access to medication-assisted treatment services for people with opioid use disorders.
Administering Agency:
SAMHSA
Learn MoreKey Details:
Funding Overview:
MAT-PDOA supports programs that expand/enhance access to medication-assisted treatment services for people with opioid use disorders.
Common Uses:
Provide medication-assisted treatment (MAT) using FDA-approved medications, conduct clinical assessments, check prescription drug monitoring program, conduct screenings and assessments, ensure that practitioners have Drug Addiction Treatment Act waivers, develop funding mechanisms for rural and resource-limited counties and municipalities, provide telehealth, provide peer support services, obtain technical assistance, and engage/screen/assess people who are incarcerated within four months of release and may benefit from MAT upon release.
Issue Area(s): Substance Use Disorder
Eligibility: CBO/Other, City, County, State, Tribal
Key Usage Options: Peer Supports, Prescription Medication, Research/Evaluation, Screening/Assessment, Staff Training
Funding Amount/Range: Up to $524,000
Allocation Frequency: Annual
Funding/Expending Period: 3 years
Funding Type: Competitive Grant
How to Obtain: Application Process
Match Requirement: No
Notes:
MAT may be provided to incarcerated individuals within four months of their release to the community.